Hypoxia

0
Pipeline Programs
3
Companies
12
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

NK
Nihon KohdenNEW YORK, NY
8 programs
Pulse OximeterN/A1 trial
Pulse OximeterN/A1 trial
Pulse OximeterN/A1 trial
Pulse OximeterN/A1 trial
Pulse oximeterN/A1 trial
+3 more programs
Active Trials
NCT07408388Active Not RecruitingEst. Dec 2027
NCT05807477CompletedEst. May 2024
NCT05807464CompletedEst. May 2024
+5 more trials
Rhythm Pharmaceuticals
3 programs
Pulse Oximeter, Respiratory Rate, Heart RateN/A1 trial
Pulse Oximeter, Respiratory Rate, Heart Rate and Arterial lineN/A1 trial
Remote Automated Monitoring SystemN/A1 trial
Active Trials
NCT05466942Completed16Est. Oct 2022
NCT05359328Completed10Est. Apr 2022
NCT05044585Completed18Est. Sep 2022
R
ResMedCA - San Diego
1 program
Portable pulsed oxygenN/A1 trial
Active Trials
NCT03182036Completed20Est. Aug 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Nihon KohdenPulse Oximeter
Nihon KohdenPulse Oximeter
Nihon KohdenPulse Oximeter
Nihon KohdenPulse Oximeter
Nihon KohdenPulse oximeter
Rhythm PharmaceuticalsPulse Oximeter, Respiratory Rate, Heart Rate and Arterial line
Nihon KohdenPulse oximeter
Rhythm PharmaceuticalsPulse Oximeter, Respiratory Rate, Heart Rate
Rhythm PharmaceuticalsRemote Automated Monitoring System
Nihon KohdenPulse oximeter
Nihon KohdenPulse oximeter
ResMedPortable pulsed oxygen

Clinical Trials (12)

Total enrollment: 64 patients across 12 trials

Pulse Oximeter Accuracy During Stable Hypoxia Plateaus

Start: Dec 2025Est. completion: Dec 2027
N/AActive Not Recruiting

Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO19)

Start: Apr 2023Est. completion: May 2024
N/ACompleted

Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO18)

Start: Apr 2023Est. completion: May 2024
N/ACompleted

Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO17)

Start: Jan 2023Est. completion: Apr 2024
N/ACompleted

Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO16)

Start: Jan 2023Est. completion: Apr 2024
N/ACompleted
NCT05359328Rhythm PharmaceuticalsPulse Oximeter, Respiratory Rate, Heart Rate and Arterial line

RDS MultiSense® SpO2 Validation Study

Start: Apr 2022Est. completion: Apr 202210 patients
N/ACompleted

Determination of SpO2 and PR Accuracy Specifications at Rest (71Ag_Vital-0031)

Start: Mar 2022Est. completion: Oct 2026
N/AActive Not Recruiting
NCT05466942Rhythm PharmaceuticalsPulse Oximeter, Respiratory Rate, Heart Rate

RDS MultiSense® SpO2 Calibration

Start: Mar 2022Est. completion: Oct 202216 patients
N/ACompleted
NCT05044585Rhythm PharmaceuticalsRemote Automated Monitoring System

Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers

Start: Sep 2021Est. completion: Sep 202218 patients
N/ACompleted

Accuracy of Pulse Oximeters With Profound Hypoxia at Rest

Start: Mar 2021Est. completion: Feb 2022
N/ACompleted

Accuracy of Pulse Oximeters With Profound Hypoxia During Motion

Start: Mar 2021Est. completion: Feb 2022
N/ACompleted
NCT03182036ResMedPortable pulsed oxygen

Portable Oxygen Concentrator Signal Capture Study

Start: May 2017Est. completion: Aug 201720 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space